Author:
Horwich A,Fossa S D,Huddart R,Dearnaley D P,Stenning S,Aresu M,Bliss J M,Hall E
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Aparicio J, Maroto P, del Muro XG, Gumà J, Sánchez-Muñoz A, Margelí M, Doménech M, Bastús R, Fernández A, López-Brea M, Terrassa J, Meana A, del Prado PM, Sastre J, Satrústegui JJ, Gironés R, Robert L, Germà JR . Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group Study. J Clin Oncol (2011) 29 (35): 4677–4681.
2. Beard CJ, Travis LB, Chen MH, Arvold ND, Nguyen PL, Martin NE, Kuban DA, Ng AK, Hoffman KE (2013) Outcomes in stage I testicular seminoma: a population-based study of 9193 patients. Cancer 119 (15): 2771–2777.
3. Bosl GJ, Patil S (2011) Carboplatin in clinical stage I seminoma: too much and too little at the same time. J Clin Oncol 29 (8): 949–952.
4. Chung PW, Daugaard G, Tyldesley S, Panzarella T, Kollmannsberger CK, Gospodarowicz MK, Warde PR (2010) Prognostic factors for relapse in stage I seminoma managed with surveillance: a validation study. J Clin Oncol 28 (Suppl): 15s (abstract 4535).
5. Classen J, Schmidberger H, Meisner C, Winkler C, Dunst J, Souchon R, Weissbach L, Budach V, Alberti W, Bamberg M German Testicular cancer study Group (2004) Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients. A trial of the German testicular cancer study group (GTCSG). Br J Cancer 90 (12): 2305–2311.
Cited by
86 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献